Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2021 May 17;5(5):CD005547.
doi: 10.1002/14651858.CD005547.pub4.

Effect of mass deworming with antihelminthics for soil-transmitted helminths during pregnancy

Rehana A Salam  1 , Jai K Das  1 , Zulfiqar A Bhutta  2
Affiliations
Meta-Analysis

Effect of mass deworming with antihelminthics for soil-transmitted helminths during pregnancy

Rehana A Salam et al. Cochrane Database Syst Rev. .

Abstract

Background: Helminthiasis is an infestation of the human body with parasitic worms. It is estimated to affect 44 million pregnancies, globally, each year. Intestinal helminthiasis (hookworm infestation) is associated with blood loss and decreased supply of nutrients for erythropoiesis, resulting in iron-deficiency anaemia. Over 50% of the pregnant women in low- and middle-income countries (LMIC) suffer from iron-deficiency anaemia. Though iron-deficiency anaemia is multifactorial, hookworm infestation is a major contributory cause in women of reproductive age in endemic areas. Antihelminthics are highly efficacious, but evidence of their beneficial effect and safety when given during pregnancy has not been established. This is an update of a Cochrane Review last published in 2015.

Objectives: To determine the effects of mass deworming with antihelminthics for soil-transmitted helminths (STH) during the second or third trimester of pregnancy on maternal and pregnancy outcomes.

Search methods: For this update, we searched Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov, the World Health Organization International Clinical Trials Registry Platform (ICTRP) (8 March 2021) and reference lists of retrieved studies.

Selection criteria: We included all prospective randomised controlled trials evaluating the effect of administration of antihelminthics versus placebo or no treatment during the second or third trimester of pregnancy; both individual-randomised and cluster-randomised trials were eligible. We excluded quasi-randomised trials and studies that were only available as abstracts with insufficient information.

Data collection and analysis: Two review authors independently assessed trials for inclusion and risk of bias, extracted data, checked accuracy and assessed the certainty of the evidence using the GRADE approach.

Main results: We included a total of six trials (24 reports) that randomised 7873 pregnant women. All of the included trials were conducted in antenatal clinics within hospitals in LMICs (Uganda, Nigeria, Peru, India, Sierra Leone and Tanzania). Among primary outcomes, five trials reported maternal anaemia, one trial reported preterm birth and three trials reported perinatal mortality. Among secondary outcomes, included trials reported maternal worm prevalence, low birthweight (LBW) and birthweight. None of the included studies reported maternal anthropometric measures or infant survival at six months. Overall, we judged the included trials to be generally at low risk of bias for most domains, while the certainty of evidence ranged from low to moderate. Analysis suggests that administration of a single dose of antihelminthics in the second trimester of pregnancy may reduce maternal anaemia by 15% (average risk ratio (RR) 0.85, 95% confidence interval (CI) 0.72 to 1.00; I²= 86%; 5 trials, 5745 participants; low-certainty evidence). We are uncertain of the effect of antihelminthics during pregnancy on preterm birth (RR 0.84, 95% CI 0.38 to 1.86; 1 trial, 1042 participants; low-certainty evidence) or perinatal mortality (RR 1.01, 95% CI 0.67 to 1.52; 3 trials, 3356 participants; low-certainty evidence). We are uncertain of the effect of antihelminthics during pregnancy on hookworm (average RR 0.31, 95% CI 0.05 to 1.93; Tau² = 1.76, I² = 99%; 2 trials, 2488 participants; low-certainty evidence). Among other secondary outcomes, findings suggest that administration of antihelminthics during pregnancy may reduce the prevalence of trichuris (average RR 0.68, 95% CI 0.48 to 0.98; I²=75%; 2 trials, 2488 participants; low-certainty evidence) and ascaris (RR 0.24, 95% CI 0.19 to 0.29; I²= 0%; 2 trials, 2488 participants; moderate-certainty evidence). Antihelminthics during pregnancy probably make little or no difference to LBW (RR 0.89, 95% CI 0.69 to 1.16; 3 trials, 2960 participants; moderate-certainty evidence) and birthweight (mean difference 0.00 kg, 95% CI -0.03 kg to 0.04 kg; 3 trials, 2960 participants; moderate-certainty evidence).

Authors' conclusions: The evidence suggests that administration of a single dose of antihelminthics in the second trimester of pregnancy may reduce maternal anaemia and worm prevalence when used in settings with high prevalence of maternal helminthiasis. Further data is needed to establish the benefit of antihelminthic treatment on other maternal and pregnancy outcomes. Future research should focus on evaluating the effect of these antihelminthics among various subgroups in order to assess whether the effect varies. Future studies could also assess the effectiveness of co-interventions and health education along with antihelminthics for maternal and pregnancy outcomes.

Trial registration: ClinicalTrials.gov NCT01132248 NCT00486863.

PubMed Disclaimer

Conflict of interest statement

Rehana A Salam: no conflict of interest

Jai K Das: no conflict of interest

Zulfiqar A Bhutta: no conflict of interest

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study
1.1
1.1. Analysis
Comparison 1: Antihelminthics versus control, Outcome 1: Maternal anaemia in third trimester (< 11 g/dL)
1.2
1.2. Analysis
Comparison 1: Antihelminthics versus control, Outcome 2: Preterm birth (birth before 37 weeks of gestation)
1.3
1.3. Analysis
Comparison 1: Antihelminthics versus control, Outcome 3: Perinatal mortality
1.4
1.4. Analysis
Comparison 1: Antihelminthics versus control, Outcome 4: Maternal worm prevalence
1.5
1.5. Analysis
Comparison 1: Antihelminthics versus control, Outcome 5: Low birthweight
1.6
1.6. Analysis
Comparison 1: Antihelminthics versus control, Outcome 6: Birthweight
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Akpan 2018 {published data only}
    1. Akpan UB, Asibong U, Okpara HC, Monjok E, Etuk S. Antenatal deworming and materno-perinatal outcomes in Calabar, Nigeria. Open Access Macedonian Journal of Medical Sciences 2018;6(5):901-7. [CENTRAL: CN-01666522] [EMBASE: 624817663] - PMC - PubMed
Deepti 2015 {published data only}
    1. Deepti SS, Nandini L. Effects of deworming during pregnancy on maternal and perinatal outcomes: A randomized controlled trial. Research Journal of Pharmaceutical, Biological and Chemical Sciences 2015;6(1):1521-6. [CENTRAL: CN-01047596] [EMBASE: 601626821]
Elliott 2005 {published data only}
    1. Elliott AM, Kizza M, Quigley MA, Ndibazza J, Nampijja M, Muhangi L, et al. The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy and early childhood. Clinical Trials 2007;4:42-57. - PMC - PubMed
    1. Elliott AM, Mpairwe H, Quigley MA, Nampijja M, Muhangi L, Oweka-Onyee J, et al. Helminth infection during pregnancy and development of infantile eczema. Journal of the American Medical Association 2005;294(16):2032-4. - PubMed
    1. Elliott AM, Namujju PB, Mawa PA, Quigley MA, Nampijja M, Nkurunziza PM, et al. A randomised controlled trial of the effects of albendazole in pregnancy on maternal responses to mycobacterial antigens and infant responses to bacille calmette-guerin (BCG) immunisation. BMC Infectious Diseases 2005;5:115. - PMC - PubMed
    1. Millard JD, Muhangi L, Sewankambo M, Ndibazza J, Elliott AM, Webb EL. Assessing the external validity of a randomized controlled trial of anthelminthics in mothers and their children in Entebbe, Uganda. Trials 2014;15(1):310. - PMC - PubMed
    1. Mpairwe H, Webb EL, Muhangi L, Ndibazza J, Akishule D, Nampijja M, et al. Antihelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised-controlled trial results. Pediatric Allergy and Immunology 2011;22(3):305-12. - PMC - PubMed
Larocque 2006 {published data only}
    1. Gyorkos TW, Gilbert NL, Larocque R, Casapia M. Trichuris and hookworm infections associated with anaemia during pregnancy [Infections au second trimestre par Trichuris et l'ankylostome, associees a l'anemie au troisieme trimestre dans une population de femmes enceintes peruviennes]. Tropical Medicine and International Health 2011;16(4):531-7. - PubMed
    1. Gyorkos TW, Larocque R, Casapia M, Gotuzzo E. Lack of risk of adverse birth outcomes after deworming in pregnant women. Pediatric Infectious Disease Journal 2006;25(9):791-4. - PubMed
    1. Larocque R, Casapia M, Gotuzzo E, MacLean JD, Soto JC, Rahme E, et al. A double-blind randomized controlled trial of antenatal mebendazole to reduce low birthweight in a hookworm-endemic area of Peru. Tropical Medicine and International Health 2006;11(10):1485–95. - PubMed
Torlesse 2001 {published data only}
    1. Torlesse H, Hodges M. Albendazole therapy and reduced decline in haemoglobin concentrations during pregnancy (Sierra Leone). Transactions of the Royal Society of Tropical Medicine and Hygiene 2001;95:195-201. - PubMed
    1. Torlesse H, Hodges M. Antihelminthic treatment and haemoglobin concentrations during pregnancy. Lancet 2000;356:1083. - PubMed
Urassa 2011 {published data only}
    1. Urassa DP, Nystrom L, Carlsted A. Effectiveness of routine antihelminthic treatment on anaemia in pregnancy in Rufiji District, Tanzania: a cluster randomised controlled trial. East African Journal of Public Health 2011;8(3):176-84. - PubMed

References to studies excluded from this review

Asbjornsdottir 2018 {published data only}
    1. Asbjornsdottir KH, Ajjampur SSR, Anderson RM, Bailey R, Gardiner I, Halliday KE, et al. Assessing the feasibility of interrupting the transmission of soil-transmitted helminths through mass drug administration: the DeWorm3 cluster randomized trial protocol [Assessing the feasibility of interrupting the transmission of soil-transmitted helminths through mass drug administration: the DeWorm3 cluster randomized trial protocol]. PLoS Neglected Tropical Diseases January 2018;12(1):e1-16. [CENTRAL: CN-01623002] [EMBASE: 620498567] - PubMed
    1. NCT03014167. Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH) [Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)]. Https://clinicaltrials.gov/show/nct03014167 (first received 2016 Dec 30). [CENTRAL: CN-01592491]
    1. The DeWorm3 Trials Team. Baseline patterns of infection in regions of Benin, Malawi and India seeking to interrupt transmission of soil transmitted helminths (STH) in the DeWorm3 trial. PLoS Neglected Tropical Diseases 2020;14(11):e0008771 https://doi.org/10.1371/journal.pntd.0008771. [CENTRAL: CN-02202287] [EMBASE: 633328479] [PMID: ] - PMC - PubMed
Basra 2013 {published data only}
    1. Basra A, Mombo-Ngoma G, Melser MC, Diop DA, Wurbel H, Mackanga JR, et al. Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial. Clinical Infectious Diseases 2013;56(6):e68-75. - PubMed
Bhutta 2007 {published data only}
    1. Bhutta Z, Klemm R, Shahid F, Rizvi A, Rah JH, Christian P. Treatment response to iron and folic acid alone is the same as with multivitamins and/or anthelminthics in severely anemic 6- to 24-month-old children. Journal of Nutrition Aug 2009;139(8):1568-74. - PubMed
    1. Bhutta ZA. Severe anaemia treatment trial, Pakistan. clinicaltrials.gov/show/NCT00116493 (first accessed 2007).
    1. Christian P, Shahid F, Rizvi A, Klemm RD, Bhutta ZA. Treatment response to standard of care for severe anemia in pregnant women and effect of multivitamins and enhanced anthelminthics. American Journal of Clinical Nutrition 2009;89(3):853-61. - PubMed
Friedman 2007 {published data only}
    1. Abioye AI, McDonald EA, Park S, Joshi A, Kurtis JD, Wu H, et al. Maternal, placental and cord blood cytokines and the risk of adverse birth outcomes among pregnant women infected with Schistosoma japonicum in the Philippines. PLoS Neglected Tropical Diseases 2019;13(6):e0007371. - PMC - PubMed
    1. NCT00486863. S. japonicum and pregnancy outcomes: a randomized, double blind, placebo controlled trial (RCT). clinicaltrials.gov/ct2/show/NCT00486863 (first accessed 15 June 2007).
    1. Olveda RM, Acosta LP, Tallo V, Baltazar PI, Lesiguez JL, Estanislao GG, et al. A randomized double blind placebo controlled trial assessing the safety and efficacy of praziquantel for the treatment of schistosomiasis during human pregnancy. In: Pediatric Academic Societies Annual Meeting; 2016 April 30-May 3; Baltimore (MD). 2016:2715.1. - PubMed
    1. Olveda RM, Acosta LP, Tallo V, Baltazar PI, Lesiguez JL, Estanislao GG, et al. Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet Infectious Diseases 2016 Feb;16(2):199-208. - PMC - PubMed
Ivan 2015 {published data only}
    1. Ivan E, Crowther NJ, Mutimura E, Rucogoza A, Janssen S, Njunwa KK, et al. Effect of deworming on disease progression markers in HIV-1-infected pregnant women on antiretroviral therapy: a longitudinal observational study from Rwanda. Clinical Infectious Diseases 2015;60(1):135-42. [PMID: ] - PubMed
Mofid 2017 {published data only}
    1. Mofid LS, Casapía M, Aguilar E, Silva H, Montresor A, Rahme E, et al. A double-blind randomized controlled trial of maternal postpartum deworming to improve infant weight gain in the Peruvian Amazon. PLoS Neglected Tropical Diseases 2017;11(1):e0005098. [CENTRAL: CN-01401425] [EMBASE: 614416205] [PMID: ] - PMC - PubMed
    1. Mofid LS, Casapía M, Montresor A, Rahme E, Fraser WD, Marquis GS, et al. Maternal deworming research study (MADRES) protocol: a double-blind, placebo-controlled randomised trial to determine the effectiveness of deworming in the immediate postpartum period. BMJ Open 2015;5(6):e008560. - PMC - PubMed
NCT04171388 (first received 2019 Nov 20)a {published data only}
    1. NCT04171388. Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health in Ethiopia [Enhancing Nutrition and Antenatal Infection Treatment for Maternal and Child Health in Amhara Region, Ethiopia]. Https://clinicaltrials.gov/show/NCT04171388 (first received 2019 Nov 20). [CENTRAL: CN-02010018]
Ndyomugyenyi 2008 {published data only}
    1. Ndyomugyenyi R, Kabatereine N, Olsen A, Magnussen P. Efficacy of ivermectin and albendazole alone and in combination for treatment of soil-transmitted helminths in pregnancy and adverse events: a randomized open label controlled intervention trial in Masindi district, western Uganda. American Journal of Tropical Medicine and Hygiene 2008;79(6):856-63. - PubMed
Nery 2013 {published data only}
    1. Nery SV, Gomes S, Traub R, McCarthy J, Llewellyn S, Andrews R, et al. Assessment of the efficacy of albendazole for the treatment of soil transmitted helminths in East Timor. American Journal of Tropical Medicine and Hygiene 2013;89(5 Suppl 1):229.
Tehalia 2011 {published data only}
    1. Tehalia MK. Impact of deworming on anaemia in pregnancy. In: 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5-9; Hyderabad, Andhra Pradesh, India. 2011:63.
Villar 1998 {published data only}
    1. Villar MA, Dala FE, Cardona VA. Nematode infections in pregnancy: the pyrantel experience. American Journal of Obstetrics and Gynaecology 1998;178(1 Pt 2):S214.

References to ongoing studies

NCT04391998 (first received 2020 May 18)a {published data only}
    1. NCT04391998. Parasitic Infection in Anemic Pregnant Women [Parasitic Infection in Anemic Pregnant Women. Prevalence and Effects in Rural Area in Egypt]. Https://clinicaltrials.gov/show/NCT04391998 (first received 2020 May 18). [CENTRAL: CN-02124718]

Additional references

Abel 2000
    1. Abel R, Rajaratnam J, Kalaimani A, Kirubakaran S. Can iron status be improved in each of the three trimesters? A community-based study. European Journal of Clinical Nutrition 2000;54:490-3. - PubMed
ACC/SCN 2000
    1. United Nations Administrative Committee on Coordination, Subcommittee on Nutrition. Fourth Report on the World Nutrition Situation. Geneva: World Health Organization, 2000.
Atukorala 1994
    1. Atukorala TM, Silva LD, Dechering WH, Dassenaeike TS, Perera RS. Evaluation of effectiveness of iron-folate supplementation and anthelminthic therapy against anaemia in pregnancy - a study in the plantation sector of Sri Lanka. American Journal of Clinical Nutrition 1994;60:286-92. - PubMed
Barry 2013
    1. Barry MA, Simon GG, Mistry N, Hotez PJ. Global trends in neglected tropical disease control and elimination: impact on child health. Archives of Disease in Childhood 2013;98(8):635-41. - PubMed
Bundy 1989
    1. Bundy DA, Cooper ES. Trichuris and trichuriasis in humans. Advances in Parasitology 1989;28:108-73. - PubMed
Bundy 1995
    1. Bundy DA, Chan MS, Savioli L. Hookworm infection in pregnancy. Transactions of the Royal Society of Tropical Hygiene and Medicine 1995;89:521-2. - PubMed
Christian 2004
    1. Christian P, Khatry SK, West KP Jr. Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal. Lancet 2004;364:981-3. - PubMed
de Silva 1999
    1. Silva NR, Sirisena JL, Gunasekera DP, Ismail MM, Silva HJ. Effect of mebendazole therapy during pregnancy on the birth outcome. Lancet 1999;353:1145-9. - PubMed
Drugs.com 2021
    1. Drugscom. Anthelmintics. www.drugs.com/drug-class/anthelmintics.html (accessed 25th January 2021).
Ghogomu 2018
    1. Ghogomu ET, Suresh S, Rayco-Solon P, Hossain A, McGowan J, Peña-Rosas JP, et al. Deworming in non-pregnant adolescent girls and adult women: a systematic review and meta-analysis. Systematic Reviews 2018;7(1):239. - PMC - PubMed
Hay 2017
    1. Hay SI, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390(10100):1260-344. - PMC - PubMed
Higgins 2011
    1. Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Hotez 1983
    1. Hotez PJ, Cerami A. Secretion of a proteolytic anticoagulant by ancylostoma duodenale hookworms. Journal of Experimental Medicine 1983;157:1594-603. - PMC - PubMed
Hotez 2014
    1. Hotez PJ, Alvarado M, Basáñez MG, Bolliger I, Bourne R, Boussinesq M, et al. The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases. PLoS Neglected Tropical Diseases 2014;8(7):e2865. - PMC - PubMed
Keiser 2008
    1. Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. Journal of the American Medical Association 2008;299(16):1937-48. - PubMed
Keiser 2019
    1. Keiser J, Utzinger J. Community-wide soil-transmitted helminth treatment is equity-effective. Lancet 2019;393(10185):2011-2. - PubMed
Montresor 1998
    1. Montresor A, Crompton DW, Hall A, Bundy DA, Savioli L, World Health Organization. Guidelines for the evaluation of soil-transmitted helminthiasis and schistosomiasis at community level: a guide for managers of control programmes. World Health Organization 1998.
Pawlowski 1991
    1. Pawlowski ZS, Schad GA, Stott GJ. Hookworm Infection And Anaemia: Approaches To Prevention And Control. Geneva: World Health Organization, 1991.
Pullan 2014
    1. Pullan RL, Smith JL, Jasrasaria R, Brooker SJ. Global numbers of infection and disease burden of soil transmitted helminth infections in 2010. Parasites & Vectors 2014;7(1):37. - PMC - PubMed
Rahman 2016
    1. Rahman MM, Abe SK, Rahman MS, Kanda M, Narita S, Bilano V, Ota E, Gilmour S, Shibuya K. Maternal anemia and risk of adverse birth and health outcomes in low-and middle-income countries: systematic review and meta-analysis. The American Journal of Clinical Nutrition 2016 Feb 1;102(2):495-504. - PubMed
Review Manager 2020 [Computer program]
    1. The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan). Version 5.4. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2020.
Salam 2019
    1. Salam RA, Cousens S, Welch V, Gaffey M, Middleton P, Makrides M, et al. Mass deworming for soil‐transmitted helminths and schistosomiasis among pregnant women: a systematic review and individual participant data meta-analysis. Campbell Systematic Reviews 2019;15(3):e1052. - PMC - PubMed
Seshadri 1997
    1. Seshadri S. Nutritional anaemia in South Asia. In: Gillespie S, editors(s). Malnutrition in South Asia. Kathmandu: United Nations Children's Fund, 1997:75-124.
Torlesse 2000
    1. Torlesse H, Hodges M. Anthelminthic treatment and haemoglobin concentrations during pregnancy. Lancet 2000;356:1083. - PubMed
Turner 2015
    1. Turner HC, Truscott JE, Hollingsworth TD, Bettis AA, Brooker SJ, Anderson RM. Cost and cost-effectiveness of soil-transmitted helminth treatment programmes: systematic review and research needs. Parasites & Vectors 2015;8(1):355. - PMC - PubMed
Welch 2017
    1. Welch VA, Ghogomu E, Hossain A, Awasthi S, Bhutta ZA, Cumberbatch C, et al. Mass deworming to improve developmental health and wellbeing of children in low-income and middle-income countries: a systematic review and network meta-analysis. Lancet Global Health 2017;5(1):e40-50. - PubMed
Welch 2019
    1. Welch VA, Hossain A, Ghogomu E, Riddle A, Cousens S, Gaffey M, et al. Deworming children for soil-transmitted helminths in low and middle-income countries: systematic review and individual participant data network meta-analysis. Journal of Development Effectiveness 2019;11(3):288-306. - PMC - PubMed
WHO 1994
    1. World Health Organization. WHO Report of the Informal Consultation on Hookworm Infection and Anaemia in Girls and Women. (WHO/CTD/SIP/96.1). Geneva: World Health Organization, 1994.
WHO 1997
    1. World Health Organization. The World Health Report 1997: Conquering Suffering, Enriching Humanity. Geneva: World Health Organization, 1997. - PubMed
WHO 2001
    1. World Health Organization. Iron Deficiency Anaemia Assessment, Prevention and Control: a Guide for Program Managers. Geneva: World Health Organization, 2001.
WHO 2003
    1. World Health Organization. Controlling Disease due to Helminth Infections. Geneva: World Health Organization, 2003.
WHO 2006
    1. World Health Organization. Preventive Chemotherapy in Human Helminthiasis. Coordinated use of Anthelminthic Drugs in Control Interventions — Guidelines for Health Professionals and Programme Managers. Geneva: World Health Organization, 2006.
WHO 2017
    1. World Health Organization. Guideline: Preventive Chemotherapy To Control Soil-transmitted Helminth Infections In At-risk Population Groups. Geneva: World Health Organization, 2017. - PubMed
WHO 2018
    1. World Health Organization. Reaching girls and women of reproductive age with deworming. Report of the Advisory Group on deworming in girls and women of reproductive age. Rockefeller Foundation Bellagio Center, Bellagio, Italy 28–30 June 2017. www.who.int/publications/i/item/WHO-CDS-NTD-PCT-2018.01 2018.

References to other published versions of this review

Haider 2009
    1. Haider BA, Humayun Q, Bhutta ZA. Effect of administration of antihelminthics for soil transmitted helminths during pregnancy. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No: CD005547. [DOI: 10.1002/14651858.CD005547.pub2] - DOI - PubMed
Salam 2015
    1. Salam RA, Haider BA, Humayun Q, Bhutta ZA. Effect of administration of antihelminthics for soil-transmitted helminths during pregnancy. Cochrane Database of Systematic Reviews 2015, Issue 6. Art. No: CD005547. [DOI: 10.1002/14651858.CD005547.pub3] - DOI - PubMed

Publication types

MeSH terms

Associated data

LinkOut - more resources